Applied Cancer Science

Oxford Vacmedix team support new University of Oxford educational initiative

The team at Oxford Vacmedix contribute to the design and the delivery of a novel MSc course in Applied Cancer Science being run by the Department of Oncology at the University of Oxford Oxford, UK – 26th February 2024 Press Release – Oxford Vacmedix support new University of Oxford educational initiative Oxford Vacmedix (OVM), the clinical stage company developing therapeutic cancer vaccines, announced today the involvement of the Management team in a brand new MSc course being run i...
Read More
en_GBEnglish